Online Psychedelics Events Bring Microdosing And Rescheduling Into The Spotlight

As psychedelics science advances toward becoming a legal health treatment option, education is paramount to shift public awareness on the potential benefits and risks of these medicines. 

Here are two upcoming options for accessing insight from industry experts.

Interactive Live Event On Psychedelic Microdosing By OPEN Foundation

The OPEN Foundation has put together an online gathering featuring “Queen of Psychedelics” Amanda Feilding (Beckley Foundation), Dr. Rotem Petranker (Canadian Centre for Psychedelic Research), mathematician Balazs Szigeti (Imperial College’s Center for Psychedelic Research), and psychologist Eline Haijen (Maastricht University.) 

See also: LSD Research Ramps Up: Full-Dose & Microdosing For Alzheimer's Studies Led By Beckley Foundation Coming Soon

The format consists of a panel discussion on the science and stories behind psychedelic microdosing, beginning with the four featured speakers who will provide an overview and their insights on the latest research on microdosing. The floor will then open to the public. 

The OPEN Foundation organizes a biannual interdisciplinary conference on psychedelics, the last of which took place in September 2022 in the Philharmonie Theatre in Haarlem (The Netherlands.)

The microdosing event will take place today, May 10, at 8PM CEST (7PM GMT, 2PM EST, 11AM PST), and is free of charge for members of the OPEN Programme or through a single-day donation.

Australian TGA Psychedelic Summit By Microdose

Following Australia’s recent rescheduling of both MDMA and psilocybin for the treatment of PTSD and Treatment-Resistant Depression (TRD), newsmedia Microdose organized an online event on the topic. 

On May 11 from 7PM to 10.30PM EST, industry experts and thought leaders including Dr. Sud Agarwal (Ingenu CRO), Josh Ismin (Psylo) and clinical psychologists Dr. Bianca Sebben and Dr. Lani Roy will discuss what this historic move means for patients in Australia and the psychedelic sector as a whole. 

The event will feature keynote speakers as well as discussion panels, covering the legislative, commercial, and therapeutic repercussions of the Australian decision.

ICYM Benzinga’s Psychedelics Capital Conference 2023

Here's some EXCLUSIVE coverage from the event’s second edition:

• Johns Hopkins Professor: Psychedelic Medicine Could Get Messy, Calls For 'Right, Smart, Non-Restrictive, Yet Preventive' Regulations

• Investing In The Unique Growth Market Of Psychedelics

• MDMA Therapy Experts Debate Upcoming Approval, Psychedelic Market Opps

• Ketamine Therapy Leaders Share Bold Vision For Future Of Psychedelics

• In Reinventing Mental Health & Next-Gen Psychedelics, 'Access And Clinical Data Are Key'

• Fireside With Enveric Biosciences's Dr. Tucker, Unlocking Psychedelic Healing Benefits

• Making The World A Better Place, How Psychedelics Are Helping

• Photo: Benzinga edit with photo by Yellow duck, nfsstudi0, Arif_Vector and Alexander Supertramp on Shutterstock.